businesspress24.com - Horizon Pharma plc to Participate in Cowen and Company 36th Annual Health Care Conference
 

Horizon Pharma plc to Participate in Cowen and Company 36th Annual Health Care Conference

ID: 1418610

(firmenpresse) - DUBLIN, IRELAND -- (Marketwired) -- 03/01/16 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients'' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will present at the Cowen and Company 36th Annual Health Care Conference at 2 p.m. ET on March 7, 2016 in Boston.

The conference presentation will be webcast live and may be accessed by visiting Horizon''s investor relations section of the website at . A replay of the webcast will be available for the event.

Horizon Pharma plc is a biopharmaceutical company focused on improving patients'' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, primary care and rheumatology business units. Horizon Pharma''s global headquarters are in Dublin, Ireland. For more information, please visit . Follow on Twitter or view careers on our page.



Investors:
John Thomas
Executive Vice President, Strategy and Investor Relations


Tina Ventura
Vice President, Investor Relations


U.S. Media:
Geoff Curtis
Senior Vice President, Corporate Communications


Ireland Media:
Ray Gordon
Gordon MRM



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Horizon Pharma plc Raises Full-Year 2016 Net Sales and Adjusted EBITDA Guidance Based on Expected Close of the Crealta Holdings LLC Acquisition
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid
Bereitgestellt von Benutzer: Marketwired
Datum: 01.03.2016 - 06:00 Uhr
Sprache: Deutsch
News-ID 1418610
Anzahl Zeichen: 3320

contact information:
Contact person:
Town:

DUBLIN, IRELAND


Phone:

Kategorie:

Trials


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 297 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Horizon Pharma plc to Participate in Cowen and Company 36th Annual Health Care Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von

Horizon Pharma plc (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Horizon Pharma plc



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 114


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.